VistaGen and Baylor College of Medicine Announce Successful Results of First-Step Target Engagement Study with VistaGen's AV-101 Focused on Treating Suicidal Ideation in Veterans; Multiple electrophysiological biomarkers indicate AV-101's NMDA receptor ta

Press/Media

Period19 Dec 2019

Media coverage

1

Media coverage

  • TitleVistaGen and Baylor College of Medicine Announce Successful Results of First-Step Target Engagement Study with VistaGen's AV-101 Focused on Treating Suicidal Ideation in Veterans; Multiple electrophysiological biomarkers indicate AV-101's NMDA receptor ta
    Media name/outletPR Newswire
    Country/TerritoryUnited States
    Date19/12/19
    PersonsSanjay Mathew